Clinical Trials Directory

Trials / Completed

CompletedNCT05139953

Impact of COVID-19 Infection During Pregnancy

Impact of COVID-19 Infection During Pregnancy on Maternal and Fetal Outcome

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

To asses impact of the COVID-19 infection during Pregnancy on maternal and fetal outcome in relation to gestational age.

Detailed description

COVID-19, caused by SARS-COV-2, was first reported in the city of Wuhan, Hubei province, China, at the end of December 2019. The exact origin of human infection has not yet been clearly identified.SARS-CoV-2 is a member of the Coronavirus family, and other pathogens from this family have inflicted a range of viral infections, including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The incubation period varies from 2 days to 2 weeks following exposure to the virus.The global pandemic caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been growing at an accelerating rate. The increasing mortality rate warrants identification and protection of the vulnerable populations in society.It is well known that pregnancy-related immune suppression makes mothers more vulnerable than non-pregnant women to several viral infections, including SARS-COV, hepatitis E virus, influenza, and herpes simplex virus. Furthermore, changes in pulmonary function during pregnancy, including decreased total lung capacity and functional residual capacity, may cause susceptibility to viral pneumonia. Data on clinical outcomes of pregnant women suffering from COVID-19 are therefore relatively scarce. Recently a meta-analysis of 13 publications reported preterm births, neonatal pneumonia, and respiratory distress syndrome in infants born of COVID-19-positive mothers. The rates of cesarean deliveries and adverse pregnancy outcomes were substantially higher

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2020-05-01
Primary completion
2021-07-31
Completion
2021-07-31
First posted
2021-12-01
Last updated
2021-12-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05139953. Inclusion in this directory is not an endorsement.